Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04150458 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Fluorocholine PET/CT Basket Trial

StatusEnrolling by Invitation
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Re-verified, no change to tracked fieldsv10
  2. Notable Trial status: Not Yet Recruiting to Enrolling by Invitation
    • Study sites: 0 to 1
    • Start date changed from estimate of Dec 2022 to Nov 30, 2022
    v9
  3. Notable Start date: Jul 2022 to Dec 2022v8
  4. Notable Start date: Dec 2021 to Jul 2022v7
  5. Notable Start date: Jun 2021 to Dec 2021v6
Show 4 earlier versionsHide 4 earlier versions
  1. Notable Start date: Dec 2020 to Jun 2021v5
  2. Notable Start date: Jun 2020 to Dec 2020v4
  3. Notable Start date: Jan 2020 to Jun 2020v3
  4. Notable Primary endpoint revised
    • Secondary endpoint revised
    v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a single-arm, open-label, phase III trial in up to 2000 patients with known or suspected benign or malignant tumors which are known or suspected to be 18F-fluorocholine-avid. Patients will receive regular standard clinical care. The only study-specific procedure will be the administration of 18F-fluorocholine followed by a PET/CT scan. Diagnostic accuracy of 18F-fluorocholine PET/CT will be captured versus a composite clinical, radiological and histopathological standard of truth at follow-up.
Trial Details
NCT Number NCT04150458
Lead Sponsor Sir Mortimer B. Davis - Jewish General Hospital
Conditions
(from sponsor)
Fluorocholine PET/CT
Enrollment 2,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov